Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer

Goldstraw, 2007, The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours, J. Thorac. Oncol., 2, 706, 10.1097/JTO.0b013e31812f3c1a Sawabata, 2011, Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade, J. Thorac. Oncol., 6, 1229, 10.1097/JTO.0b013e318219aae2 Kawaguchi, 2010, Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC, J. Thorac. Oncol., 5, 620, 10.1097/JTO.0b013e3181d2dcd9 Attaran, 2012, A propensity-matched comparison of survival after lung resection in patients with a high versus low body mass index, Eur. J. Cardiothorac. Surg., 42, 653, 10.1093/ejcts/ezs135 Jagoe, 2001, The influence of nutritional status on complications after operations for lung cancer, Ann. Thorac. Surg., 71, 936, 10.1016/S0003-4975(00)02006-3 Cruz-Jentoft, 2010, Sarcopenia: European consensus on definition and diagnosis: report of the european working group on sarcopenia in older people, Age Ageing, 39, 412, 10.1093/ageing/afq034 International agency for research on cancer, 2004 International Union Against Cancer. The TNM Classification of Malignant Tumors, 7th Edition. 2009. Harimoto, 2013, Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma, Br. J. Surg., 100, 1523, 10.1002/bjs.9258 van Vledder, 2012, Body composition and outcome in patients undergoing resection of colorectal liver metastases, Br. J. Surg., 99, 550, 10.1002/bjs.7823 Harvie, 2003, Changes in body composition in men and women with advanced nonsmall cell lung cancer (NSCLC) undergoing chemotherapy, J. Hum. Nutr. Diet, 16, 323, 10.1046/j.1365-277X.2003.00459.x Prado, 2007, Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity, Clin. Cancer Res., 13, 3264, 10.1158/1078-0432.CCR-06-3067 Barret, 2014, Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer, Nutr. Cancer, 66, 583, 10.1080/01635581.2014.894103 Prado, 2009, Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment, Clin. Cancer Res., 15, 2920, 10.1158/1078-0432.CCR-08-2242 Iritani, 2015, Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma, J. Gastroenterol., 50, 323, 10.1007/s00535-014-0964-9 Collins, 2014, The assessment and impact of sarcopenia in lung cancer: a systematic literature review, BMJ Open, 4, e003697, 10.1136/bmjopen-2013-003697 Prado, 2008, Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study, Lancet Oncol., 9, 629, 10.1016/S1470-2045(08)70153-0 Martin, 2013, Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index, J. Clin. Oncol., 31, 1539, 10.1200/JCO.2012.45.2722 Kovarik, 2014, Clinically relevant determinants of body composition, function and nutritional status as mortality predictors in lung cancer patients, Lung Cancer, 84, 1, 10.1016/j.lungcan.2014.01.020 Fearon, 2011, Definition and classification of cancer cachexia: an international consensus, Lancet Oncol., 12, 489, 10.1016/S1470-2045(10)70218-7 van der Meij, 2013, Pre-cachexia and cachexia at diagnosis of stage III non-small-cell lung carcinoma: an exploratory study comparing two consensus-based frameworks, Br. J. Nutr., 109, 2231, 10.1017/S0007114512004527 Prado, 2013, Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential, Am. J. Clin. Nutr., 98, 1012, 10.3945/ajcn.113.060228 James, 2015, Obesity in breast cancer–what is the risk factor?, Eur. J. Cancer, 51, 705, 10.1016/j.ejca.2015.01.057 Palomares, 1996, Gender influence on weight-loss pattern and survival of nonsmall cell lung carcinoma patients, Cancer, 78, 2119, 10.1002/(SICI)1097-0142(19961115)78:10<2119::AID-CNCR12>3.0.CO;2-1 Chansky, 2009, The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer, J. Thorac. Oncol., 4, 792, 10.1097/JTO.0b013e3181a7716e Van Cutsem, 2005, The causes and consequences of cancer-associated malnutrition, Eur. J. Oncol. Nurs., 9, S51, 10.1016/j.ejon.2005.09.007 Faber, 2015, Improved body weight and performance status and reduced serum PGE2 levels after nutritional intervention with a specific medical food in newly diagnosed patients with esophageal cancer or adenocarcinoma of the gastro-esophageal junction, J. Cachexia Sarcopenia Muscle, 6, 32, 10.1002/jcsm.12009